Epidemiology of Glucose-6-Phosphate Dehydrogenase Deficiency in Arab Countries: Insights from a Systematic Review

AS Alangari, AA El-Metwally, A Alanazi… - Journal of Clinical …, 2023 - mdpi.com
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a common metabolic disorder
affecting more than 400 million individuals worldwide. Being an X-linked disorder, the …

[PDF][PDF] Glucose-6-phosphate dehydrogenase deficiency among neonates with jaundice in Africa; systematic review and meta-analysis

W Kassahun, A Tunta, A Abera, M Shiferaw - Heliyon, 2023 - cell.com
Abstract Background Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a genetic
disorder caused by a structural abnormality in the enzyme. G6PD deficiency is most …

Kinetics of glucose-6-phosphate dehydrogenase (G6PD) activity during Plasmodium vivax infection: implications for early radical malaria treatment

L Dahuron, J Goungounga, M Drame, M Douine… - Malaria Journal, 2024 - Springer
Background Plasmodium vivax relapses due to dormant liver hypnozoites can be prevented
with primaquine. However, the dose must be adjusted in individuals with glucose-6 …

Bridging the Knowledge Gap: Associations between malaria infections, personally used prevention measures, and risk factors in Al Gezira State, Sudan

MA Salah, H AbdElbagi, O Fathelrahman, AE Ahmed… - 2023 - researchsquare.com
Background: The burden of malaria continues to disproportionately affect Low-and middle-
income countries (LMICs), including Sudan, due to various risk factors that influence malaria …

Assessment of Glucose-6 phosphate dehydrogenase deficiency in malaria suspected patients attending at Shele and Lante Health Center, Southern Ethiopia

MT Negash, SM Feleke, E Lo, D Nega, A Abebe… - 2022 - researchsquare.com
Background In Ethiopia, an estimated 68 million peoples are at risk of malaria–60% caused
by Plasmodium falciparum and 40% by Plasmodium vivax. The national elimination program …